Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Article Title Journal
Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel Clinical Oncology
Learning Conditional Variational Autoencoders with Missing Covariates arXiv
A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma Cancer Chemotherapy and Pharmacology
Impact of the Economic Status of the Patient's Country of Residence on the Outcome of Oncology Clinical Trials The Oncologist
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects Nature Communications
Prognostic significance of baseline neutrophil–lymphocyte ratio in patients with non-small-cell lung cancer: a pooled analysis of open phase III clinical trial data futuremedicine
Artificial Intelligence Comes of Age in the Fight Against Cancer Oncology Times
Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581 The American Journal of Surgery
Generalizable EHR-R-REDCap pipeline for a national multi-institutional rare tumor patient registry Jamia Open
Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer Journal of Biopharmaceutical Statistics
A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics ASCPT
Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response Statistics in Medicine
Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis BMC Cancer
Analysis of composite endpoints with component-wise censoring in the presence of differential visit schedules Statistics in Medicine

Pages